Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 411 followers
Latest posts
Last updated 1 day ago
The Next Frontier in Patient Support: Connected Data, AI and Personalized Engagement
1 day ago
Life sciences leaders are rethinking patient support as AI, connected data and...
Lilly's Zepbound remains physicians' favorite, even as oral obesity launches altar landscape
1 day ago
Injected weight loss drugs remain favored over newer oral treatments by a...
Novo Nordisk makes Omnicom agency of record for US media buying
1 day ago
Novo Nordisk has made Omnicom the agency of record for U.S. media...
AbbVie’s Skyrizi retakes edge in pharma’s July ad spending league
1 day ago
AbbVie retook the top spot from rival J&J and its immunology drug...
‘It’s been a roller coaster’: Novo Nordisk’s CFO reflects on ‘pressure’ to drive growth
1 day ago
Novo Nordisk CFO Karsten Munk Knudsen spoke to Fierce the morning the...
Fresenius Kabi recalls mislabeled morphine lot that could cause overdose death
1 day ago
Fresenius Kabi voluntary recalled one lot of morphine sulfate injection due to...
Fierce Pharma Asia—Takeda’s historic narcolepsy nod; Daiichi’s accounting error; Astellas’ revenue beat
1 day ago
Takeda's first-in-class orexin treatment won an FDA nod for narcolepsy. Daiichi Sankyo...
VerilyMe, Bausch + Lomb visualize dry eye education in new collaboration
2 days ago
The partnership marks Basuch + Lomb's foray into the digital and AI...
Replimune secures FDA approval for melanoma therapy Tudriqev after long regulatory battle
2 days ago
In a remarkable turnaround, Replimune has reversed the fortune of its melanoma...
Sarepta’s new CEO Michael Severino faces critical milestones to prove growth
2 days ago
In his first earnings call just days after becoming Sarepta Therapeutics' CEO...
Takeda gains FDA nod for first-in-class narcolepsy treatment Orzeyful
2 days ago
After coming up short with two OX2R agonists, Takeda has scored with...
Sanofi asked to change Dupixent ads after Galderma challenge
3 days ago
Galderma Laboratories has landed a blow on Sanofi in its multi-case advertising...